Skip to main content

Texas Biologics logo

☰

  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
    • Biology & Machine Learning
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events
  • Home
  • About
    • Overview
    • What are Biologics?
    • Executive Committee
    • News
  • Research
    • Our Approach
    • Current Projects
    • Core Facilities
    • Advanced Protein Therapeutics Core
  • Programs
    • Pilot Grants
    • Core Facility Support
    • Clinical Trials Unit
    • Biology & Machine Learning
  • Commercialization
    • Therapeutics Pipeline
    • Technology Partnering
    • Commercialization Partners
    • Resources for Faculty and Students
  • Get Involved
    • Partner with Us
    • Prospective Students
    • Giving
    • Contact
  • Events

↑

About

About

  • Overview
  • What are Biologics?
  • Executive Committee
  • News
    • In the Media

News

New Cancer Treatment Uses Enzymes to Boost Immune System and Fight Back

Details
September 04, 2018

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy.

Page 6 of 6

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

UT Austin logo

©

The University of Texas at Austin | Privacy Policy | Web Accessibility

Cockrell School of Engineering
College of Natural Sciences 
Dell Medical School
Resources
  • Contact Us
  • News

Give